Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04203641
What this trial is testing

L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Helix BioPharma Corporation 28
Testing effectiveness (Phase 2)UnknownNCT06235918
What this trial is testing

Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomasResectable Head and Neck Squamous-cell Carcinoma
Xiang Lu 30
Early research (Phase 1)Study completedNCT00356460
What this trial is testing

Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Who this might be right for
Carcinoma, Renal CellMelanoma
Genzyme, a Sanofi Company 29
Not applicableUnknownNCT02734680
What this trial is testing

IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70
Testing effectiveness (Phase 2)UnknownNCT04974879
What this trial is testing

Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Qingdao Central Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02501603
What this trial is testing

Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Yonsei University 72
Very early researchLooking for participantsNCT05916261
What this trial is testing

Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Ruijin Hospital 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04172779
What this trial is testing

Erlotinib for Hepatocellular Carcinoma Chemoprevention

Who this might be right for
Cirrhosis, LiverAdvanced Liver Fibrosis
University of Texas Southwestern Medical Center 60
Very early researchLooking for participantsNCT07395479
What this trial is testing

A Platform Study of In Vivo CAR-T for Treating Advanced Malignant Tumors Based on Target Screening

Who this might be right for
Advanced Malignant Tumours
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Not applicableEnded earlyNCT02017496
What this trial is testing

Safety of Breast Conserving Treatment in Locally Advanced Breast Cancer Receiving Neoadjuvant Treatment

Who this might be right for
Breast Cancer
Oslo University Hospital 18
Early research (Phase 1)Study completedNCT01222546
What this trial is testing

Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Chugai Pharma Europe Ltd. 38
Early research (Phase 1)Study completedNCT00020488
What this trial is testing

Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Early research (Phase 1)WithdrawnNCT05262842
What this trial is testing

JS001+IMP4297 in Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
Shanghai Junshi Bioscience Co., Ltd.
Large-scale testing (Phase 3)UnknownNCT02960061
What this trial is testing

Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer

Who this might be right for
Survival
Sixth Affiliated Hospital, Sun Yat-sen University 640
Early research (Phase 1)Ended earlyNCT03139370
What this trial is testing

Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers

Who this might be right for
Solid Tumor
Kite, A Gilead Company 16
Post-approval studies (Phase 4)Not Yet RecruitingNCT07302841
What this trial is testing

Tunlametinib + AG + Cetuximab β as First-Line Therapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Tianjin Medical University Cancer Institute and Hospital 28
Not applicableUnknownNCT02219854
What this trial is testing

Single-center Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
Third Affiliated Hospital, Sun Yat-Sen University 178
Testing effectiveness (Phase 2)Ended earlyNCT00376805
What this trial is testing

Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 6
Testing effectiveness (Phase 2)Study completedNCT03065400
What this trial is testing

PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

Who this might be right for
Chronic Phase MyelofibrosisPrimary MyelofibrosisPost-essential Thrombocythemia Myelofibrosis+1 more
John Mascarenhas 10
Early research (Phase 1)Looking for participantsNCT07042100
What this trial is testing

Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
Sun Pharma Advanced Research Company Limited 177
Next Page